Original Research ARTICLE
A polygenic risk score derived from episodic memory weighted genetic variants is associated with cognitive decline in preclinical Alzheimer’s disease
- 1Edith Cowan University, Australia
- 2Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia
- 3Macquarie University, Australia
- 4Florey Institute of Neuroscience and Mental Health, Australia
- 5Cogstate, Australia
- 6The University of Melbourne, Australia
- 7Austin Health, University of Melbourne, Australia
- 8Curtin University, Australia
Studies of Alzheimer’s disease risk-weighted polygenic risk scores (PRSs) for cognitive performance have reported inconsistent associations. This inconsistency is particularly evident when PRSs are assessed independent of APOE genotype. As such, the development and assessment of phenotype-specific weightings to derive PRSs for cognitive decline in preclinical AD is warranted. To this end a episodic memory-weighted PRS (emPRS) was derived and assessed against decline in cognitive performance in 226 healthy cognitively normal older adults with high brain Aβ-amyloid burden participants from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. The effect size for decline in a verbal episodic memory was determined individually for 27 genetic variants in a reference sample (n=151). These were then summed to generate a emPRS either including APOE (emPRSc¯APOE) or excluding APOE (emPRSs¯APOE). Resultant cwPRS were then evaluated, in a test sample (n=75), against decline in global cognition, verbal episodic memory and a pre-Alzheimer’s cognitive composite (AIBL-PACC) over 7.5 years. The mean (SD) age of the 226 participants was 72.2 (6.6) years and 116 (51.3%) were female. Reference and test samples did not differ significantly demographically. Whilst no association of cwPRSs were observed with baseline cognition, the emPRSc¯APOE was associated with longitudinal global cognition (-0.237, P=.0002), verbal episodic memory (-0.259, P=.00003) and the AIBL-PACC (-0.381, P=.02). The emPRSs¯APOE was also associated with global cognition (-0.169, P=.021) and verbal episodic memory (-0.208, P=.004). Stratification by APOE 4 revealed that the association between the emPRS and verbal episodic memory was limited to carriage of no 4 or one 4 allele. This was also observed for global cognition. The emPRS and rates of decline in AIBL-PACC were associated in those carrying one 4 allele. Overall, the described novel emPRS has utility for the prediction of decline in cognition in preclinical AD. This study provides evidence to support the further use and evaluation of phenotype weightings in PRS development.
Keywords: Polygenic risk score, Alzheimer's disease, Aβ-amyloid, cognitive decline, episodic memory
Received: 05 Jul 2018;
Accepted: 06 Dec 2018.
Edited by:Nibaldo C. Inestrosa, Pontificia Universidad Católica de Chile, Chile
Reviewed by:Cristian Bonvicini, Centro San Giovanni di Dio Fatebenefratelli (IRCCS), Italy
Sid O'Bryant, University of North Texas Health Science Center, United States
Copyright: © 2018 Porter, Burnham, Savage, Lim, Maruff, Milicic, Peretti, Ames, Masters, Martins, Rainey-Smith, Rowe, Salvado, Taddei, Groth, Verdile, Villemagne and Laws. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: PhD. Simon M. Laws, Edith Cowan University, Joondalup, 6027, Australia, email@example.com